Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Objectives To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. Design Systematic review and meta-analysis of randomised and observational studies. Data sources Medline, Em...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ
Autors principals: Li, Ling, Li, Sheyu, Deng, Ke, Liu, Jiali, Vandvik, Per Olav, Zhao, Pujing, Zhang, Longhao, Shen, Jiantong, Bala, Malgorzata M, Sohani, Zahra N, Wong, Evelyn, Busse, Jason W, Ebrahim, Shanil, Malaga, German, Rios, Lorena P, Wang, Yingqiang, Chen, Qunfei, Guyatt, Gordon H, Sun, Xin
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group Ltd. 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772781/
https://ncbi.nlm.nih.gov/pubmed/26888822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.i610
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars